Company profile: QT Medical
1.1 - Company Overview
Company description
- Provider of cloud-connected cardiac monitoring devices, including PCA 500, a compact wireless 12-lead ECG with pre-positioned single-use electrodes and HIPAA-compliant cloud data management; single-use electrode strips for quick, accurate lead placement; and Xpress ECG, an online mail-delivery at-home 12-lead ECG service with cloud uploads for remote physician review.
Products and services
- PCA 500: Compact, wireless 12-lead ECG system utilizing pre-positioned single-use electrodes to streamline accurate cardiac monitoring, with data securely managed in a HIPAA-compliant cloud
- Xpress ECG: Cloud-based online order mail-delivery service for 12-lead ECGs, letting patients perform tests at home and upload results to the cloud for remote review by physicians
- Electrode Strip: Single-use, pre-positioned electrode strips designed for quick, accurate lead placement in ECG tests, reducing infection risk and placement errors
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to QT Medical
Action Pharma
HQ: Denmark
Website
- Description: Provider of R&D-focused drug discovery and development, creating pharmaceutical products and treatment concepts for cardiovascular and inflammatory diseases and acquired metabolic diseases, including type-II diabetes and obesity; product pipeline includes AP214.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Action Pharma company profile →
FoxHollow Technologies
HQ: United States
Website
- Description: Provider of medical devices for the treatment of peripheral artery disease (PAD) and other cardiovascular disease, including the SilverHawk Plaque Excision System, a minimally-invasive catheter system that removes plaque to reopen narrowed or blocked arteries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FoxHollow Technologies company profile →
Cardio Polymers
HQ: United States
Website
- Description: Provider of biocompatible polymer implant therapies and implantable devices to treat chronic heart failure, mitral valve regurgitation, and postoperative atrial fibrillation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardio Polymers company profile →
Applied Therapeutics
HQ: United States
Website
- Description: Provider of drug development targeting molecules/pathways in fatal or debilitating diseases, with programs: govorestat for Galactosemia (pediatric Phase 3 completed; MAA validated; NDA accepted; PDUFA date set), SORD Deficiency (positive pilot; ongoing Phase 3), PMM2-CDG (Phase 2-ready; Expanded Access), AT-001 for Diabetic Cardiomyopathy/Peripheral Neuropathy (Phase 3), and AT-003 for Diabetic Retinopathy (Phase 1-ready).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied Therapeutics company profile →
Amarin
HQ: Ireland
Website
- Description: Provider of prescription cardiovascular therapy and clinical research, including VASCEPA/VAZKEPA (icosapent ethyl) to reduce cardiovascular risk in patients with elevated triglycerides and established cardiovascular disease, and the REDUCE-IT global outcomes study evaluating VASCEPA in patients with controlled LDL-C and elevated triglycerides to reduce cardiovascular events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amarin company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for QT Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to QT Medical
2.2 - Growth funds investing in similar companies to QT Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for QT Medical
4.2 - Public trading comparable groups for QT Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →